GINA VERTERAMO: Open Payments
NPI 1609502608 · MISHAWAKA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 13 payments from 4 companies in 2025. Trend: 2023 $207 · 2024 $259 · 2025 $391
Food & beverage: $282Education: $110
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $186 |
| Boston Scientific Corporation | 1 | $112 |
| Lilly USA, LLC | 3 | $75 |
| Ethicon US, LLC | 1 | $18 |
Products named: Wegovy, WATCHMAN FLX, ECHELON ENDOPATH, MOUNJARO, ZEPBOUND.
Industry payments across IN — which companies pay providers there.
